Healthcare provider profile · identity verified

Mark R Firth, MD

Internal Medicine · ATHENS, GA · NPI 1710098496

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	625	164
Losartan Potassium	Losartan Potassium	419	115
Levothyroxine Sodium	Levothyroxine Sodium	412	111
Rosuvastatin Calcium	Rosuvastatin Calcium	336	93
Lisinopril	Lisinopril	256	59
Pravastatin Sodium	Pravastatin Sodium	246	62
Atorvastatin Calcium	Atorvastatin Calcium	240	61
Escitalopram Oxalate	Escitalopram Oxalate	223	48
Metformin Hcl Er	Metformin Hcl	186	43
Simvastatin	Simvastatin	150	37
Gabapentin	Gabapentin	149	38
Sertraline Hcl	Sertraline Hcl	144	26
Alprazolam	Alprazolam	125	26
Clonazepam	Clonazepam	120	23
Omeprazole	Omeprazole	117	32
Zolpidem Tartrate	Zolpidem Tartrate	112	31
Indapamide	Indapamide	111	33
Eliquis	Apixaban	102	17
Metoprolol Succinate	Metoprolol Succinate	102	25
Tramadol Hcl	Tramadol Hcl	101	24
Azithromycin	Azithromycin	99	80
Glipizide	Glipizide	93	21
Duloxetine Hcl	Duloxetine Hcl	91	17
Meloxicam	Meloxicam	86	25
Bupropion Xl	Bupropion Hcl	80	20
Eszopiclone	Eszopiclone	80	15
Pantoprazole Sodium	Pantoprazole Sodium	76	22
Tamsulosin Hcl	Tamsulosin Hcl	76	19
Famotidine	Famotidine	75	19
Lovastatin	Lovastatin	75	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	71	17
Allopurinol	Allopurinol	69	18
Metformin Hcl	Metformin Hcl	65	18
Ozempic	Semaglutide	63	suppressed
Prednisone	Prednisone	61	16
Hydrochlorothiazide	Hydrochlorothiazide	60	16
Furosemide	Furosemide	58	12
Lorazepam	Lorazepam	56	20
Trazodone Hcl	Trazodone Hcl	56	12
Glimepiride	Glimepiride	52	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	19
Fluticasone Propionate	Fluticasone Propionate	48	11
Montelukast Sodium	Montelukast Sodium	47	13
Potassium Chloride	Potassium Chloride	47	11
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	11
Metoprolol Tartrate	Metoprolol Tartrate	44	13
Oxybutynin Chloride Er	Oxybutynin Chloride	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	suppressed
Ondansetron Odt	Ondansetron	41	suppressed
Labetalol Hcl	Labetalol Hcl	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	39	11
Tradjenta	Linagliptin	39	suppressed
Repatha Sureclick	Evolocumab	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	suppressed
Atenolol	Atenolol	37	suppressed
Jardiance	Empagliflozin	36	suppressed
Temazepam	Temazepam	36	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	12
Methylprednisolone	Methylprednisolone	34	32
Fenofibrate	Fenofibrate Nanocrystallized	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Enalapril Maleate	Enalapril Maleate	31	suppressed
Estradiol	Estradiol	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	24
Clonidine Hcl	Clonidine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Cefuroxime	Cefuroxime Axetil	26	21
Januvia	Sitagliptin Phosphate	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Valsartan	Valsartan	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	22
Verapamil Er	Verapamil Hcl	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	23	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Finasteride	Finasteride	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Colchicine	Colchicine	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Spironolactone	Spironolactone	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Glipizide Er	Glipizide	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Nystatin	Nystatin	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Ranolazine Er	Ranolazine	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Metronidazole	Metronidazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error